0001127602-24-020307.txt : 20240711
0001127602-24-020307.hdr.sgml : 20240711
20240711184106
ACCESSION NUMBER: 0001127602-24-020307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240709
FILED AS OF DATE: 20240711
DATE AS OF CHANGE: 20240711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desjarlais John R
CENTRAL INDEX KEY: 0001591313
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36182
FILM NUMBER: 241112930
MAIL ADDRESS:
STREET 1: C/O XENCOR, INC.
STREET 2: 111 WEST LEMON AVENUE
CITY: MONROVIA
STATE: CA
ZIP: 91016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xencor Inc
CENTRAL INDEX KEY: 0001326732
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 201622502
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
BUSINESS PHONE: 626-305-5900
MAIL ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-07-09
0001326732
Xencor Inc
XNCR
0001591313
Desjarlais John R
C/O XENCOR, INC.
465 N HALSTEAD STREET, SUITE 200
PASADENA
CA
91107
1
SR. VICE PRESIDENT & CSO
0
Common Stock
2024-07-09
4
M
0
42215
10.73
A
228648
D
Common Stock
2024-07-09
4
S
0
36329
18.319
D
192319
D
Common Stock
2024-07-10
4
M
0
7785
10.73
A
200104
D
Stock Option (Right to Buy)
10.73
2024-07-09
4
M
0
42215
0
D
2024-07-13
Common Stock
42215
7785
D
Stock Option (Right to Buy)
10.73
2024-07-10
4
M
0
7785
0
D
2024-07-13
Common Stock
7785
0
D
This transaction is pursuant to a 10b5-1 plan.
Underlying option due to expire in July 2024.
Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
25% of the shares subject to the option shall vest on the one year anniversary of July 14, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
/s/ Celia E. Eckert, Attorney-in-Fact
2024-07-11